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BIOCOMPATIBILITY STUDIES OF LOCAL ANTIBIOTIC-ELUTING DEVICES FOR 
ORTHOPEDICS APLICATIONS  
M. Gimeno1, P. Pinczowski1, G. Mendoza2, F.J. Vázquez1, M. Pérez3, J. Asín1, J. Santamaría3, M. 
Arruebo2 and L. Luján1 
[1] Department of Animal Pathology, University of Zaragoza, Spain, [2] Department of Chemical 
Engineering, Aragon Institute of Nanoscience, University of Zaragoza, Spain" and "Networking Research 
Center on Bioengineering, Biomaterials and Nanomedicine, CIBER-BBN, Madrid, Spain, [3] Department of 
Animal Anatomy, Embryology and Genetics. University of Zaragoza, Spain. 
Introduction: Efficient local antibiotic-eluting devices could be an alternative to deliver locally therapeutic 
antibiotics at target tissues, avoiding bacterial contamination on implanted materials and minimizing side 
effects. A proper assessment of biocompatibility of the biomaterials used is of utmost importance to 
guarantee their safety after implantation. We present cytotoxicological studies and implantation tests results 
to evaluate the biocompatibility of two drug-eluting systems with potential use in orthopedic implants. 
Materials and Methods Cytotoxicological studies were carried out by evaluating the in-vitro dose-
dependent effect of cefazolin and linezolid in fibroblasts, keratinocytes (HaCaT), macrophages (THP1) and 
osteoblasts. Cells were incubated with antibiotic concentrations ranging from 0.25 to 1.5 mg/ml. Cellular 
viability was assessed by using the Alamar Blue test. Cell cycle and apoptosis were measured by flow 
cytometry. Short-term implantation tests were performed in an ovine model to assess the device’s local 
pathological effects. Two hollow antibiotic-loaded implants were used, (A) macroporous stainless steel 
reservoir loaded with linezolid and (B) stainless steel pins with orifices drilled in the reservoir wall loaded 
with cefazolin. Implants were placed in the sheep’s tibia. Tissues were studied by pathological means, 
focusing on determining the local effect and tissue response under the presence of the implanted device. 
Results: Cytotoxic effects of cefazolin and linezolid were only found for the highest concentrations tested 
(1.5 mg/mL) on keratinocytes and osteoblasts, respectively.. There were no significant changes on cell cycle 
and apoptosis at the dose studied (1.0mg/mL). Sheep with both A and B antibiotic-loaded implants did not 
show any evidence of local or systemic adverse effects. 
Conclusions: These results showed no potential toxic effects for the designed devices. However, the 
antibiotic local concentration should not exceed 1.0 mg/mL. 
 
 
